Amrutanjan Health Care Limited
AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink.
What Amrutanjan files
- Others41
- Dividend/Bonus14
- Important14
- PPTs7
- Board Meeting6
- Results4
Amrutanjan Health Care delivered strong FY26 results with Net Sales up 11.23% to Rs 502.55 Cr and Profit After Tax rising 13.95% to Rs 57.92 Cr. Profit before exceptional items jumped 25.47%. Growth was driven by power brands Amrutanjan and Comfy, with Pain Management (+10%) and Women's Hygiene (+19%) segments...
Here's the concise, retail-friendly summary: **1. Business Performance:** Amrutanjan Health Care posted strong Q3 net sales of 141.04 Cr (+14.9%) and YTD sales of 352.78 Cr (+11.5%). Pain Management (Amrutanjan) and Women's Hygiene (Comfy) drove growth; Comfy's Q3 sales rose 22.6%, boosted by XL variants. **2. Growth Drivers or Strategy:**...
AHCL delivered a strong H1 FY26, with Net Sales up 9.35% to 211.75 Cr, PBT soaring 36.88% to 30.51 Cr, and PAT climbing 35.71% to 22.27 Cr, showcasing robust operating leverage. Q2 also saw healthy growth. Pain Management was a star performer, growing 16% in H1, fueled by Maha Strong...
**1. Financial Highlights:** AHCL's Q1 FY26 saw Net Sales up 12.31% to ₹94.05 Cr. PBT surged 77.80% to ₹11.29 Cr, PAT jumped 79.87% to ₹8.31 Cr. Pain Management grew 26%, Comfy 11%. Rehydration sales declined 17%. Management aims for 13% operating profit margin (from 11.44%). **2. Strategic Initiatives & Growth...
1. Financial Highlights: Amrutanjan posted net sales of Rs. 451.82 Cr in FY25, up 7.3%, with profit after tax rising 13% to Rs. 50.83 Cr. Q4 sales grew 6.6% to Rs. 135.41 Cr, and PAT increased 11.1% to Rs. 15.18 Cr. The OTC segment, including Comfy, expanded 17.8% to Rs....